4828265
Last Update Posted: 2022-01-31
Recruiting has ended
Males accepted | 18 Years-65 Years |
36 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
This is an open-label study to assess safety, tolerability, and pharmacokinetics of Aldafermin (NGM282) in healthy adult male Japanese and non-Japanese subjects
Eligibility
Relevant conditions:
Healthy Male
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov